Rapid clearance of antigen complexes using novel antibodies
US9738722B2 · kind B2 · utility
7Cited by
120References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 15, 2014 |
| Grant date | Aug 22, 2017 |
| Priority date | — |
| Expiry date | Dec 18, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/32
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to rapid clearance molecules that bind target antigens and FcγRIIb with increased affinity as compared to parent molecules, the compositions being capable of causing accelerated clearance of such antigens. Such compositions are useful for treating a variety of disorders, including allergic diseases, atherosclerosis, and a variety of other conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.